Weifang Hospital of Traditional Chinese Medicine
6
2
2
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 6 trials
33%
2 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Monitoring and Rehabilitation for ICIACI Rehabilitation:A Cohort Study
Role: collaborator
ICIAM Rehabilitation Program Study: A Randomized Controlled Trial
Role: collaborator
Wearable Devices Assist in the Detection, Screening, and Management of Major Diseases in Middle-aged and Elderly Populations
Role: collaborator
Effects of Different Pressure Garments on Upper Extremity Sensorimotor Functions and Quality of Life After Stroke
Role: collaborator
Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage
Role: collaborator
Bevacizumab in Patients With Severe Covid-19
Role: collaborator
All 6 trials loaded